Peter Carmeliet
Peter Carmeliet
hoogleraar, Universiteit van Leuven, VIB
Verifierad e-postadress på kuleuven.vib.be
Titel
Citeras av
Citeras av
År
Angiogenesis in cancer and other diseases
P Carmeliet, RK Jain
nature 407 (6801), 249-257, 2000
98352000
Mechanisms of angiogenesis and arteriogenesis
P Carmeliet
Nature medicine 6 (4), 389-395, 2000
49592000
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
P Carmeliet, V Ferreira, G Breier, S Pollefeyt, L Kieckens, M Gertsenstein, ...
Nature 380 (6573), 435-439, 1996
47821996
Angiogenesis in health and disease
P Carmeliet
Nature medicine 9 (6), 653-660, 2003
47072003
Molecular mechanisms and clinical applications of angiogenesis
P Carmeliet, RK Jain
Nature 473 (7347), 298-307, 2011
39502011
Angiogenesis in life, disease and medicine
P Carmeliet
Nature 438 (7070), 932-936, 2005
37282005
Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
H Zhong, AM De Marzo, E Laughner, M Lim, DA Hilton, D Zagzag, ...
Cancer research 59 (22), 5830-5835, 1999
32131999
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
P Carmeliet, Y Dor, JM Herbert, D Fukumura, K Brusselmans, ...
Nature 394 (6692), 485-490, 1998
29021998
Basic and therapeutic aspects of angiogenesis
M Potente, H Gerhardt, P Carmeliet
Cell 146 (6), 873-887, 2011
19182011
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet, L Moons, A Luttun, V Vincenti, V Compernolle, M De Mol, ...
Nature medicine 7 (5), 575-583, 2001
18332001
Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis
P Carmeliet, MG Lampugnani, L Moons, F Breviario, V Compernolle, ...
Cell 98 (2), 147-157, 1999
14181999
Hypoxia and inflammation
HK Eltzschig, P Carmeliet
New England Journal of Medicine 364 (7), 656-665, 2011
13702011
uPAR: a versatile signalling orchestrator
F Blasi, P Carmeliet
Nature reviews Molecular cell biology 3 (12), 932-943, 2002
13582002
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
A Luttun, M Tjwa, L Moons, Y Wu, A Angelillo-Scherrer, F Liao, JA Nagy, ...
Nature medicine 8 (8), 831-840, 2002
12702002
VEGF as a key mediator of angiogenesis in cancer
P Carmeliet
Oncology 69 (Suppl. 3), 4-10, 2005
12592005
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
P Carmeliet, RK Jain
Nature reviews Drug discovery 10 (6), 417-427, 2011
12022011
Molecular mechanisms of blood vessel growth
EM Conway, D Collen, P Carmeliet
Cardiovascular research 49 (3), 507-521, 2001
11832001
Physiological consequences of loss of plasminogen activator gene function in mice
P Carmeliet, L Schoonjans, L Kieckens, B Ream, J Degen, R Bronson, ...
Nature 368 (6470), 419-424, 1994
11691994
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
B Oosthuyse, L Moons, E Storkebaum, H Beck, D Nuyens, K Brusselmans, ...
Nature genetics 28 (2), 131-138, 2001
11212001
Gene prioritization through genomic data fusion
S Aerts, D Lambrechts, S Maity, P Van Loo, B Coessens, F De Smet, ...
Nature biotechnology 24 (5), 537-544, 2006
9792006
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20